ORMP

Oramed Pharmaceuticals Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$4.03

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %2.4 / %30

Non-compliant assets / Total market cap %81.1 / %30

Non-compliant revenue / Total income %100 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes.

Website

Analysis (Turkish): ORMP Hissesi Caiz mi, Helal mi? Oramed Pharmaceuticals Inc. Katılım Analizi